These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 2039029
61. [Antibiotic prophylaxis in cardiovascular surgery: comparison of sulbactam-ampicillin and cefuroxime]. Girotto M, Comoglio C, Donegani E, Di Summa M. Riv Eur Sci Med Farmacol; 1993; 15(1):43-6. PubMed ID: 8159835 [Abstract] [Full Text] [Related]
62. Comparison of cefoxitin, cefotetan and the combination of ampicillin with sulbactam in the therapy of polymicrobial infection in mice. Brook I. J Antimicrob Chemother; 1994 Nov; 34(5):791-6. PubMed ID: 7706175 [Abstract] [Full Text] [Related]
63. Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. McKinnon PS, Paladino JA, Grayson ML, Gibbons GW, Karchmer AW. Clin Infect Dis; 1997 Jan; 24(1):57-63. PubMed ID: 8994756 [Abstract] [Full Text] [Related]
64. Clinical effect of ampicillin with beta-lactamase inhibitor (sulbactam/ampicillin) on community-acquired pneumonia in the elderly. Okimoto N, Kurihara T, Honda N, Asaoka N, Fujita K, Ohba H, Nakamura J. J Infect Chemother; 2003 Jun; 9(2):183-6. PubMed ID: 12825120 [Abstract] [Full Text] [Related]
65. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections. Betrosian AP, Douzinas EE. Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991 [Abstract] [Full Text] [Related]
67. [A study on pharmacokinetics, antimicrobial activity and clinical efficacy of sultamicillin in children]. Okazaki H, Kitamura N, Hirabayashi Y, Higashino H, Kobayashi Y. Jpn J Antibiot; 1988 Dec; 41(12):1940-6. PubMed ID: 3249366 [Abstract] [Full Text] [Related]
69. Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy. Hiraki Y, Yoshida M, Masuda Y, Inoue D, Tsuji Y, Kamimura H, Karube Y, Takaki K, Kawano F. Int J Infect Dis; 2013 Dec; 17(12):e1234-6. PubMed ID: 23791858 [Abstract] [Full Text] [Related]
70. [Activity of an ampicillin/sulbactam combination in respiratory infections]. Mangiarotti P, Manara G, Grassi G, Gialdroni Grassi G. G Ital Chemioter; 1989 Dec; 36(1-3):39-44. PubMed ID: 2488911 [Abstract] [Full Text] [Related]
75. Intramuscular sulbactam/ampicillin combination therapy in gynaecological and obstetric bacterial infections. Abbassi AF, Said A, Gaber A. J Int Med Res; 1991 Dec; 19 Suppl 1():44A-49A. PubMed ID: 2060693 [Abstract] [Full Text] [Related]
77. [The efficacy of sulbactam-ampicillin in preventing postoperative infections in gynecology and obstetrics. A comparative open study]. Ahued Ahued R, Leal del Rosal JA, Rocha del Valle G, Sereno Colo JA. Ginecol Obstet Mex; 1994 Sep; 62():282-4. PubMed ID: 7959156 [Abstract] [Full Text] [Related]
78. Randomized comparative trial with ampicillin/sulbactam versus cefamandole in the therapy of community acquired pneumonia. Williams D, Perri M, Zervos MJ. Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):293-8. PubMed ID: 8070432 [Abstract] [Full Text] [Related]
79. In-vitro antimicrobial studies with the combination of cefoperazone and sulbactam. Greenberg RN, Baker M, Meade DW, Chang Y, Danko LS. J Antimicrob Chemother; 1993 Dec; 32(6):912-3. PubMed ID: 8144438 [No Abstract] [Full Text] [Related]
80. Efficacy of ampicillin/sulbactam combination in experimental shunt infections caused by Staphylococcus epidermidis. A light and scanning electron microscope study. Gedikoğlu Y, Colak A, Benli K, Erbengi T. J Neurosurg Sci; 1993 Mar; 37(1):19-23. PubMed ID: 8366363 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]